Speed to Market in MedTech: How Post-Manufacturing Integration Accelerates Launch

Getting a medical device to market isn’t just about design and manufacturing.  

In this episode of MedTech Unboxed, Steve and Donald Inglis, Senior Manager, Technical Services Engineering, at Millstone Medical, discuss why post-manufacturing can become a major bottleneck, especially when sterile packaging, validation, and third-party lab testing aren’t planned early enough.  

Donald explains why these downstream steps often create unexpected delays and how MedTech teams can avoid them by treating packaging and post-manufacturing as part of the launch strategy from the start, alongside design for manufacturability and automation.

The conversation also covers how Millstone helps clients move faster through pre-validated packaging, fast-track lab testing, and a more integrated end-of-line model. Donald breaks down how that approach can simplify processes that are often fragmented and validation-heavy, helping MedTech teams reduce delays and get products to market faster. 

What you’ll hear in this episode: 

• Why post-manufacturing often becomes a bottleneck when packaging, cleaning, sterilization, and validation are not planned early enough
• What pre-validated sterile packaging actually includes, from PETG trays to Tyvek and nylon pouch options
• How five-year real-time aging data and sterilization compatibility can reduce validation time for new launches
• What fast-track lab testing looks like across cleaning, packaging, and sterilization validation
• How Millstone’s blueprint for success, first-month action plan, and stage-gated execution help teams launch faster